Evidence-Based Liver Chemistry Monitoring in Drug Development

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.23, Iss.3, 2009-06, pp. : 149-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guidelines for monitoring of methotrexate therapy: “Evidence‐based medicine” outside of clinical trials

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2706-2709

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence-Based Medicine Criteria Applied to Hypolipidemic and Antihypertensive Drug Trials: Is Drug Efficacy Always the Same?

By Calabresi L. Sirtori C.R.

Pharmacological Research, Vol. 37, Iss. 5, 1998-05 ,pp. : 339-343

Academic Press

Access to resources Recommend Favorite

Lithium: Updated Human Knowledge Using an Evidence-Based Approach: Part II: Clinical Pharmacology and Therapeutic Monitoring

By >

CNS Drugs, Vol. 23, Iss. 4, 2009-01 ,pp. : 331-349

Adis International

Access to resources Recommend Favorite

Evidence-based design

Pharmacy World and Science, Vol. 26, Iss. 5, 2004-10 ,pp. : 245-245

Springer Publishing Company

Access to resources Recommend Favorite

Evidence-based follitropin

By Cunha-Filho Joao Sabino

Reproductive BioMedicine Online, Vol. 13, Iss. 2, 2006-08 ,pp. : 155-156

Reproductive Healthcare Ltd

Access to resources Recommend Favorite